Virtu Financial LLC Ocular Therapeutix, Inc Transaction History

Virtu Financial LLC

  • $1.43 Billion
  • Q2 2024

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 26, 2024
BUY
$2.08 - $4.52 $129,097 - $280,538
62,066 New
62,066 $277,000
Q2 2023

Jul 27, 2023
BUY
$4.6 - $7.64 $61,561 - $102,246
13,383 New
13,383 $69,000
Q3 2021

Nov 12, 2021
SELL
$9.7 - $14.34 $122,617 - $181,271
-12,641 Closed
0 $0
Q2 2021

Sep 17, 2021
SELL
$13.43 - $19.16 $44,278 - $63,170
-3,297 Reduced 20.69%
12,641 $179,000
Q1 2021

May 19, 2021
BUY
$15.82 - $22.11 $252,139 - $352,389
15,938 New
15,938 $262,000
Q4 2020

Feb 24, 2021
SELL
$7.91 - $22.95 $153,920 - $446,584
-19,459 Closed
0 $0
Q3 2020

Dec 11, 2020
BUY
$7.36 - $9.87 $143,218 - $192,060
19,459 New
19,459 $148,000
Q2 2020

Aug 07, 2020
SELL
$4.67 - $8.95 $223,319 - $427,988
-47,820 Closed
0 $0
Q4 2019

Feb 04, 2020
BUY
$2.57 - $4.73 $96,978 - $178,486
37,735 Added 374.17%
47,820 $189,000
Q3 2019

Nov 20, 2019
BUY
$3.04 - $5.32 $30,658 - $53,652
10,085 New
10,085 $31,000
Q2 2018

Jul 30, 2018
SELL
$5.99 - $8.17 $123,825 - $168,890
-20,672 Closed
0 $0
Q2 2018

Jul 30, 2018
BUY
$5.99 - $8.17 $3,192 - $4,354
533 Added 2.65%
20,672 $140,000
Q1 2018

May 14, 2018
SELL
$4.66 - $7.08 $199,825 - $303,597
-42,881 Reduced 68.04%
20,139 $131,000
Q4 2017

Feb 09, 2018
BUY
$3.73 - $6.37 $235,064 - $401,437
63,020
63,020 $280,000

Others Institutions Holding OCUL

# of Institutions
151
Shares Held
136M
Call Options Held
86.4K
Put Options Held
263K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $668M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email